Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study
Overweight, obesity and combined metabolic abnormalities are increasingly being identified in people living with type 1 diabetes, further accelerating the risk of microvascular and macrovascular complications. Early identification of the presence of combined metabolic abnormalities should enable therapeutic interventions to be modified towards multifactorial approaches, with attention to education on avoidance of overweight (e.g. dietary counselling) in addition to strict glycaemic control and intensification of use of antihypertensive agents and statins. Use of adjunct therapies in this population as a tool should be explored more thoroughly to reduce risk of complications.
Authors
- Michel Vandenbroucke
- Philippe Oriot (ORCID: https://orcid.org/0000-0002-9810-0303)
- Christophe De Block (ORCID: https://orcid.org/0000-0002-0679-3203)
- Laurent Crenier (ORCID: https://orcid.org/0000-0003-2326-4108)
- Frank Nobels (ORCID: https://orcid.org/0000-0002-8058-8734)
- Chantal Mathieu (ORCID: https://orcid.org/0000-0002-4055-5233)
- Astrid Lavens (ORCID: https://orcid.org/0000-0002-9942-8263)
- An-Sofie Vanherwegen (ORCID: https://orcid.org/0000-0002-0195-3060)
- Jean‐Christophe Philips (ORCID: https://orcid.org/0000-0003-4131-6936)
Institutions
- University of Liège (BE)
- Erasmus Hospital (BE)
- Onze Lieve Vrouwziekenhuis Hospital (BE)
- Antwerp University Hospital (BE)
- Centre Hospitalier de Mouscron (BE)
- Centre Hospitalier Universitaire de Liège (BE)
- Sciensano (Belgium) (BE)
Publication Details
- Journal
- Diabetologia
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1007/s00125-024-06273-7
- Citations
- 15
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 5.37
Funders
- Institut National d'assurance Maladie-Invalidité